Brief: Medivir's Patent Application For Fostrox Approved In China

Medivir AB

19/06/2023 07:49

June 19 (Reuters) - Medivir AB  MEDIVIR.ST :
    * PATENT APPLICATION FOR FOSTROX APPROVED IN CHINA
    * PATENT IS VALID UNTIL 2035 WITH EXTENSIONS OF UP TO 5 YEARS EXPECTED IN KEY MARKETS

Source text for Eikon:  ID:nWkr1JcPFM 
Further company coverage:  MEDIVIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))